A simple score incorporating 6 clinical and angiographic characteristics can help predict the risk of clinically driven restenosis in patients receiving a drug-eluting stent (DES), according to a study based on a large, all-comers registry. The findings were published online July 6, 2010, ahead of print in Circulation: Cardiovascular Interventions.
